Carlsmed, Inc. (CARL) stock forecast and price target
Price $17.12 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($17.12)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.51 | +23.2% | $79M |
| Next fiscal year ends December 31, 2027 | $-1.56 | −3.3% | $112M |
| Quarter after ends December 31, 2026 | $-0.35 | −18.9% | $24M |
Consensus of the analysts covering Carlsmed, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 28.5% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Carlsmed’s intrinsic value about 87% below today’s market value, and it scores 1.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Carlsmed stock price target?
The average 12-month target from 5 analysts is $22.00, 28.5% above the current price of $17.12 Targets range from $18.00 to $26.00.
Is Carlsmed a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Carlsmed expected to earn?
Analysts expect EPS of $-1.51 for the fiscal year ending December 31, 2026 and $-1.56 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.